BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 33822057)

  • 21. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
    van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
    Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
    Friis Wang N; Bogstad JW; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
    Hum Reprod; 2023 Sep; 38(9):1807-1815. PubMed ID: 37354554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.
    Humaidan P; Nelson SM; Devroey P; Coddington CC; Schwartz LB; Gordon K; Frattarelli JL; Tarlatzis BC; Fatemi HM; Lutjen P; Stegmann BJ
    Hum Reprod; 2016 Sep; 31(9):1997-2004. PubMed ID: 27343272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial.
    Boudry L; Mateizel I; Wouters K; Papaleo E; Mackens S; De Vos M; Racca A; Adriaenssens T; Tournaye H; Blockeel C
    Hum Reprod; 2024 Mar; 39(3):538-547. PubMed ID: 38199789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
    Lobo R; Soerdal T; Ekerhovd E; Cohlen B; Porcu E; Schenk M; Shufaro Y; Smeenk J; Suerdieck MB; Pinton P; Pinborg A;
    Hum Reprod; 2024 May; ():. PubMed ID: 38723189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial.
    Bosch E; Alamá P; Romero JL; Marí M; Labarta E; Pellicer A
    Hum Reprod; 2024 Feb; 39(2):393-402. PubMed ID: 38037188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates.
    Uyanik E; Mumusoglu S; Polat M; Yarali Ozbek I; Esteves SC; Humaidan P; Yarali H
    Hum Reprod; 2023 Feb; 38(2):225-236. PubMed ID: 36478179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count.
    Guzman L; Ortega-Hrepich C; Polyzos NP; Anckaert E; Verheyen G; Coucke W; Devroey P; Tournaye H; Smitz J; De Vos M
    Hum Reprod; 2013 May; 28(5):1261-6. PubMed ID: 23427238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.
    Polyzos NP; Neves AR; Drakopoulos P; Spits C; Alvaro Mercadal B; Garcia S; Ma PQM; Le LH; Ho MT; Mertens J; Stoop D; Tournaye H; Vuong NL
    Hum Reprod; 2021 May; 36(6):1711-1721. PubMed ID: 33889959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
    Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
    Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
    Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B;
    Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of children born from IVM versus IVF: 2-year follow-up of a randomized controlled trial.
    Vuong LN; Nguyen MHN; Nguyen NA; Ly TT; Tran VTT; Nguyen NT; Hoang HLT; Le XTH; Pham TD; Smitz JEJ; Mol BW; Norman RJ; Ho TM
    Hum Reprod; 2022 Jul; 37(8):1871-1879. PubMed ID: 35595193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.